test

Oleg Nodelman

@Ecor1 Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$2.922BTotal holdings63
Assets growth rate-10.62%Assets growth rate (2-Q avg)-13.97%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Ecor1 Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 63 positions.

Assets under management

The assets under management (AUM) of Ecor1 Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.922B in assets, with a quarterly growth rate of -10.62% and a 2-quarter average growth rate of -13.97%. The portfolio is managed by Oleg Nodelman, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CNTACentessa Pharmaceuticals Plc
Recent Activity
Decreased -43.58%
1.77%
$51.549M
3.224M shares@ $15.99 avg price
ITOSIteos Therapeutics Inc
Recent Activity
Decreased -50.5%
0.57%
$16.424M
1.609M shares@ $10.21 avg price
LENZLenz Therapeutics Inc
Recent Activity
Decreased -71.57%
0.29%
$8.232M
346,772 shares@ $23.74 avg price
GLPGGalapagos Nv
Recent Activity
Decreased -97.3%
0.16%
$4.463M
155,006 shares@ $28.8 avg price
PRQRProqr Thrapeutics N V
Recent Activity
Decreased -10.12%
0.12%
$3.342M
1.836M shares@ $1.83 avg price